FDA Adverse Event Injury Summary report: N

DUROM ACETABULAR COMPONENT 56/50 CODE P

MDR report key: 2860478 · Received December 5, 2012

Report

Report Number
9613350-2012-01125
Event Type
Injury
Date Received
December 5, 2012
Date of Event
November 8, 2012
Report Date
November 8, 2012
Manufacturer
ZIMMER GMBH
Product Code
KWA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
NL
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THE MANUFACTURER DID NOT RECEIVE DEVICES OR X-RAYS FOR REVIEW. WHERE LOT NUMBERS WERE RECEIVED FOR THE DEVICES, THE DEVICE HISTORY RECORDS WERE REVIEWED AND FOUND TO BE CONFORMING. BASED ON AN EXTENSIVE INVESTIGATION OF EVENTS REPORTED FROM SEVERAL USER FACILITIES OUTSIDE THE U.S., ZIMMER IDENTIFIED THAT THE MOST PROBABLE CAUSE FOR THE OUTCOME OBSERVED WAS A LOOSE OR UNSTABLE CUP THAT RESULTED FROM USE OF SURGICAL TECHNIQUES NOT CONSISTENT WITH THE MANUFACTURER'S RECOMMENDATIONS. AS A CORRECTIVE ACTION, A RETRAINING PROGRAM FOR USERS OUTSIDE THE U.S. WAS INITIATED IN NOVEMBER 2009 AND REPORTED TO THE NATIONAL COMPETENT AUTHORITIES AS REQUIRED. THE DUROM CUP REPORTED IN THIS CASE IS NOT MARKETED IN THE U.S. A SIMILAR CUP, COMPATIBLE WITH THE METASUL LDH FEMORAL HEAD, IS CLEARED IN THE U.S. AND A CORRECTIVE ACTION FOR THIS PRODUCT WAS REPORTED TO THE FDA IN JULY 2008 AS CORRECTION Z-2415/2426-2008. SHOULD ADDITIONAL INFORMATION INCLUDING THE FINAL INVESTIGATION RESULT BE AVAILABLE, THAT CHANGES THIS ASSESSMENT, AN AMENDED MEDICAL DEVICE REPORT WILL BE FILED. THE NEED FOR FURTHER CORRECTIVE MEASURES IS NOT INDICATED AT THIS TIME AND ZIMMER (B)(4) CONSIDERS THIS CASE AS CLOSED. (B)(4).

Description of Event or Problem · 1

IT IS REPORT THAT THE PATIENT RECEIVED AN ACETABULAR CUP AND UNDERWENT A REVISION SURGERY DUE TO PAIN, HIGH METAL BLOOD LEVELS AND PSEUDOTUMOR.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 DUROM ACETABULAR COMPONENT 56/50 CODE P DUROM ACETABULAR COMPONENT AND METASUL KWA ZIMMER GMBH 2234322

Patients

Seq Age Sex Outcome Treatment
1 56 YR Hospitalization| R